Biomoda President John Cousins to Appear Live on MN1.com, Key Investor Internet Program

ALBUQUERQUE, N.M., May 8 /PRNewswire-FirstCall/ -- Biomoda, Inc. , Albuquerque, New Mexico, (http://www.biomoda.com), maker of patented early lung cancer detection testing and other cancer diagnostic technology, announced today that John Cousins, President, will appear live at 10 a.m. Central Standard Time, 11 a.m. Eastern, 8 a.m. Pacific on the popular MN1.com market news show on Wednesday, May 9, to discuss Biomoda's achievements and future outlook.

Investors and others interested in the Company can hear the interview live at http://www.MN1.com . Market News First is the only online, live, IPTV provider bringing market news and features to interested investors. It is noted for its one-on-one interviews with executives of public companies to deliver the answers to the questions that shareholders are asking.

"It is important that we use venues such as this to tell our outstanding story and to interest investors in Biomoda and our patented technologies for the early discovery of cancers including lung cancer," said Mr. Cousins.

"Safe Harbor" Statement: This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and are naturally subject to uncertainty and changes in circumstances. Actual results may vary materially from expectations contained herein. Biomoda is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT: Biomoda, Inc., Albuquerque John Cousins, President 505-821-0875 Paul Knopick E & E Communications 949/707-5365 pknopick@eandecommunications.com

Biomoda, Inc.

CONTACT: John Cousins, President of Biomoda, Inc., Albuquerque,+1-505-821-0875; or Paul Knopick of E & E Communications, +1-949-707-5365,pknopick@eandecommunications.com, for Biomoda, Inc.

MORE ON THIS TOPIC